RecruitingPhase 3NCT05774951
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Sponsor: AstraZeneca
Laconia, NH · +126 more sites
1 recruiting breast cancer studies with a site in Laconia, NH.
Sponsor: AstraZeneca
Laconia, NH · +126 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.